DUBLIN, Oct. 3, 2017 /PRNewswire/ -- Today Allergan plc (NYSE:AGN) announced the FDA approval of BOTOX ® Cosmetic for its third indication, the temporary improvement in the appearance of moderate to ...
Occasionally, when the toxin is injected, it can travel to unintended areas. In some cases, you could experience a droopy eyelid after Botox. When Botox migrates to one or both of two specific areas, ...
* FDA approval of Botox cosmetic for improvement in appearance of moderate to severe forehead lines realted to frontalis muscle activity in adults Source text for Eikon: Further company coverage: ...
Botox Cosmetic is already approved for the temporary improvement of crow's feet lines and frown lines between the eyebrows in adults. Allergan has announced that Botox Cosmetic (onabotulinumtoxinA) ...